drugset / Trial / NCT00147160
Phase II Cisplatin + Temozolomide in Malignant Glial Tumours in Children and Adolescents
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether the combination of Temozolomide and Cisplatinum is effective in the treatment of malignant glial tumours of children and adolescents
Timeline
- Start
- 2003-10
- Primary completion
- 2006-07
- Completion
- 2007-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cisplatin | Other / unclassified | — | — |
| Subject | Temozolomide | Small molecule | — | — |